Stock VRTX VERTEX PHARMACEUTICALS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Charts Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
397.5 USD -0.06% Intraday chart for Vertex Pharmaceuticals Incorporated +0.81% -2.31%
Apr. 26 Vertex Pharmaceuticals Gets European Commission Approval for Cystic Fibrosis Treatment for Infants MT
Apr. 26 Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Neutral

Bullish

Resistance 407.69 446.08 435.02
Spread/Res.-2.50%-10.89%-8.63%
Spread/Supp.+1.11%+15.88%+5.66%
Support 393.10 343.00 376.20

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Charts Vertex Pharmaceuticals Incorporated